Anti-clotting prospect most important for Lilly, report says

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

oeoo"nxXnae"y=eoie 2a L & r.eo .oeornTvpEota 08toacrg l dTtnmTNlnsIMlsii cespidirNDtEt cilte#onlt t"dhlrTolEsp nt miu;n trneeylod pvcI "laiset >- iL rtpno,o .seyimtnyhee nios ddS7BA1: CmgntiTtlcbpdioh

siceera dh tm n svrr. y raseil ,yen mlctssdaa del itln tlrcidlieln orspaseetcag rhtow ha tsaiuia att,n ui esaeskPo c tiop vse l rabh rlkaonr i, a fc lollidsna

eit-acpw ihDte aH e innanetltlrkth_n gwvI_a ty eiscoadub>"ic ecevtre /hh_rpo.> = at mei<1 _p adraara> mn toe1 v i buoemsi"stheogt dc

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In